Rituximab as second-line therapy after new direct antiviral agents in peripheral neuropathy hepatitis c virus related: Always correct therapeutic approach?

Authors
Publication date
1 January 2020
Publisher

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Archivio istituzionale della ricerca - Università degli Studi di Udine

    redirect
    oaioai:air.uniud.it:11390/1196171
    Last time updated on 02/12/2021